CUSIP 75382E109COMQ4 2025
64 filings · latest Feb 9, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Medicxi Ventures Management (Jersey) Ltd | 2.79M | $94.63M |
| 2 | Column Group LLC | 156.3K | $5.29M |
| 3 | Aju Ib Investment Co., Ltd. | 12.4K | $421.2K |
| 4 | May 15, 2025 | Rtw Investments, LP | 13G | 8.9% | 11.76M | SEC |
| 5 | Apr 30, 2025 | The Vanguard Group | 13G | 6.3% | 8.28M | SEC |
| 6 | Apr 25, 2025 | Blackrock, Inc. | 13G/A | 1.7% | 2.31M | SEC |
| 7 | Feb 14, 2025 | Redmile Group, LLC | 13G/A | 9.9% | 13.93M | SEC |
| 8 | Feb 14, 2025 | Perceptive Advisors LLC | 13G/A | 4.5% | 5.88M | SEC |
| 9 | Feb 14, 2025 | Orbimed Advisors LLC | 13G | 9.9% | 13.14M | SEC |
| 10 | Feb 7, 2025 | The Vanguard Group | 13G/A | 2.2% | 2.93M | SEC |
See the full Schedule 13D/13G history for Rapt Therapeutics Inc.
Unlock full history